Notch Intracellular Domain Plasmid Delivery via Poly(Lactic-Co-Glycolic Acid) Nanoparticles to Upregulate Notch Pathway Molecules

Victoria L. Messerschmidt, Uday Chintapula, Aneetta E. Kuriakose, Samantha Laboy, Thuy Thi Dang Truong, Le Naiya A. Kydd, Justyn Jaworski, Zui Pan, Hesham Sadek, Kytai T. Nguyen, Juhyun Lee

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Notch signaling is a highly conserved signaling system that is required for embryonic development and regeneration of organs. When the signal is lost, maldevelopment occurs and leads to a lethal state. Delivering exogenous genetic materials encoding Notch into cells can reestablish downstream signaling and rescue cellular functions. In this study, we utilized the negatively charged and FDA approved polymer poly(lactic-co-glycolic acid) to encapsulate Notch Intracellular Domain-containing plasmid in nanoparticles. We show that primary human umbilical vein endothelial cells (HUVECs) readily uptake the nanoparticles with and without specific antibody targets. We demonstrated that our nanoparticles are non-toxic, stable over time, and compatible with blood. We further demonstrated that HUVECs could be successfully transfected with these nanoparticles in static and dynamic environments. Lastly, we elucidated that these nanoparticles could upregulate the downstream genes of Notch signaling, indicating that the payload was viable and successfully altered the genetic downstream effects.

Original languageEnglish (US)
Article number707897
JournalFrontiers in Cardiovascular Medicine
Volume8
DOIs
StatePublished - 2021

Keywords

  • Notch signaling
  • PLGA
  • gene delivery
  • nanoparticles
  • non-viral transfection

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Notch Intracellular Domain Plasmid Delivery via Poly(Lactic-Co-Glycolic Acid) Nanoparticles to Upregulate Notch Pathway Molecules'. Together they form a unique fingerprint.

Cite this